July/August 2015 Vol 8 No 5

Editorial

Ahead of the Curve

David B. Nash, MD, MBA

Perspectives

Guiding Employer Management of Specialty Drugs

Cheryl Larson, F. Randy Vogenberg, PhD, FASHP

Regulatory

Trends in Medicare Part D Medication Therapy Management Eligibility Criteria

Junling Wang, PhD, Ya-Chen Tina Shih, PhD, Yolanda Qin, Theo Young, BS, Zachary Thomas, MS, MBA, Christina A. Spivey, PhD, David K. Solomon, BSc, PharmD, Marie Chisholm-Burns, PharmD, MPH, MBA, FCCP, FASHP, J. Warren Salmon, PhD

Stakeholder Perspective

Is It Time to Revisit Medicare Part D?

by J. Warren Salmon, PhD

Original Research

Value-Based Benefit Design to Improve Medication Adherence for Employees with Anxiety or Depression

Kimberly J. Reid, MS, Kathleen M. Aguilar, MPH, Eric Thompson, MBA, Ross M. Miller, MD, MPH

Stakeholder Perspective

Counting on a Run of Value-Based Benefit Design

by Albert Tzeel, MD, MHSA, CPE, FAAPL

Industry Trends

US Healthcare Annual Spending Estimated to Rise by 5.8% on Average Through 2024

Laura Morgan

Resource Utilization for Chemotherapy-Induced Nausea and Vomiting Events in Patients with Solid Tumors Treated with Antiemetic Regimens

Lee Schwartzberg, MD, Brooke Harrow, PhD, Lincy S Lal, PharmD, PhD, Janna Radtchenko, MBA, Gary H. Lyman, MD, MPH

Stakeholder Perspective

Impact of Chemotherapy-Induced Nausea and Vomiting Treatment on Patient Outcomes and Resource Utilization

by James T. Kennedy, Jr, RPh, MBA

Results 1 - 6 of 6

Subscribe Today!

To sign up for our newsletter or print publications, please enter your contact information below.

I'd like to receive:

AHDB Print Edition

AHDB Weekly e‑Newsletter

I have reviewed and consent to the terms of AHDB's Privacy Policy, and AHDB has my permission to retain my information in its database, and to forward pertinent communications to me.